Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.
Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.
Recruiting · NCT04627753 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL. | primary central nervous system lymphoma | Recruiting | Phase 2 | 2026-04-23 | NCT04627753 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Celltrion | 14 |
| Kim, Seok Jin | 2 |
| Samyang Biopharmaceuticals Corporation | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Samsung Medical Center | Seoul | South Korea | 1 |